Nicolas Penel, MD, PhD
Centre Oscar Lambret
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Nicolas Penel, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:02 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT01303094 · Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue SarcomaCentre Oscar Lambret · completed · Soft Tissue Sarcoma, Uterine Sarcoma · principal investigator
- Ph2NCT01303497 · Efficacity of Weekly Paclitaxel in Association or Not With Bevacizumab in Metastatic or Locally Advanced AngiosarcomasCentre Oscar Lambret · completed · Angiosarcoma · principal investigator
- Ph2NCT00874874 · Sorafenib in Treating Patients With Angiosarcoma That is Locally Advanced, Metastatic, or Unable to Be Removed by SurgeryCentre Oscar Lambret · completed · Sarcoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:02 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.